The global market for ventricular hypertrophy treatment is projected to rise considerably in the coming years. This growth can be attributed to a mixture of factors, including an aging population, rising prevalence of cardiovascular diseases, and advancements in therapies available. The is propelled by a desire for effective cures for ventricular